Announcements Trials
Browse Landscape

Phase

Phase 2 128Phase 1 118Phase 1/2 68Phase NA 35Phase 3 22Phase EARLY_PHASE1 6Phase 4 5Phase 2/3 3

Status

Completed 98Unknown 62Recruiting 20Terminated 14Not yet recruiting 10Active not recruiting 7Withdrawn 5Enrolling by invitation 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 16Breast 12Tumor-Agnostic 5Thoracic 5Lymphoid 5Genitourinary 4CNS 4Plasma cell 3Other hematologic neoplasm 3Head & Neck 3Dermatologic 3Classical hematology 3Gynecologic 2Other 1NET 1Myeloid 1Endocrine 1

Conditions

Lymphoma, Follicular 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteoporosis 1Opioid-Related Disorders 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Leukemia, Myeloid, Acute 1Febrile Neutropenia 1Alzheimer Disease 1

Interventions

R-CHOP protocol 1Micafungin 1Meropenem 1Donepezil 1Crizotinib 1Buprenorphine, Naloxone Drug Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Withdrawn × Lymphoid × Clear all
NCT04091009 2025-12-31

Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms

Massachusetts General Hospital

Phase 4 Withdrawn
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

NCT05784844 2024-09-19

Antimicrobial Revision in Persistent Febrile Neutropenia

Wake Forest University Health Sciences

Phase 4 Withdrawn
Classical hematologyLymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT02487316 2016-12-30

A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib

Peking University

Phase 4 Withdrawn
Lymphoid

Lymphoma, Large-Cell, Anaplastic

NCT01841814 2016-12-05

LYMPHOS

Centre Hospitalier Universitaire, Amiens

Phase 4 Withdrawn
Lymphoid

Lymphoma, Osteoporosis

NCT00711204 2012-12-10

Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease

Eisai Inc.

Phase 4 Withdrawn
Lymphoid

Alzheimer Disease, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡